Drupal.behaviors.print = function(context) {window.print();window.close();}>
VelaDx, Thomas Jefferson Co-developing MDx for Cancer, Infectious Diseases
January 30, 2013
VelaDx, Thomas Jefferson Co-developing MDx for Cancer, Infectious Diseases
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
Qiagen Plans Mid-Year Launch of Clinical NGS Platform; Says Gene Panels will Complement RT-PCR Tests
January 9, 2013 / Clinical Sequencing News
VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News
CollabRx, U. of Chicago Medical Center Collaborate on NGS Data Interpretation
June 18, 2013 / GenomeWeb Daily News
Alacris Attains Illumina CSPro Certification for NGS
June 11, 2013 / GenomeWeb Daily News